ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: The well-known triggering molecular event initiating the CML is a chromosomal translocation between chromosomes 9 and 22, t (9;22), leading to the formation of a fusion onco-protein (BCR-ABL1) which is characterized by an overactive tyrosine kinase activity [4].